MERCK ACCESS AND SUPPORT

Before taking ZEPATIER, please read the accompanying Patient Information, including information about the risk of the hepatitis B virus (HBV) becoming active again in patients who have ever had HBV infection, and discuss it with your doctor. The Prescribing Information also is available.
 
WELCOME TO
MERCK ACCESS
AND SUPPORT
 
ARE YOU A US HEALTH CARE PROFESSIONAL?
Yes
No

 

HOW MAY WE ASSIST YOU?

The Merck Access Program can help answer your questions about insurance coverage
and potential financial assistance options
 
  • Does my insurance cover ZEPATIER?
  • What options may be available for co-pay assistance?
  • Should I be referred to the Merck Patient Assistance Program?
 
A representative may be able to
  • Research your insurance benefits
  • Obtain information about your out-of-pocket costs
  • Provide information on possible co-pay assistance options
  • Refer you to the Merck Patient Assistance Program
  • Answer questions about completing the Enrollment Form
Questions? Call The Merck Access Program at 866-251-6013 Mon–Fri, 8 AM to 8 PM (ET),
to speak with a representative.
Model
Contact The Merck Access Program for ZEPATIER® (elbasvir and grazoprevir)